195 related articles for article (PubMed ID: 36008464)
21. Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression.
Mudduluru G; Ilm K; Fuchs S; Stein U
Oncotarget; 2017 Mar; 8(13):21081-21094. PubMed ID: 28423501
[TBL] [Abstract][Full Text] [Related]
22. S100A4 drives non-small cell lung cancer invasion, associates with poor prognosis, and is effectively targeted by the FDA-approved anti-helminthic agent niclosamide.
Stewart RL; Carpenter BL; West DS; Knifley T; Liu L; Wang C; Weiss HL; Gal TS; Durbin EB; Arnold SM; O'Connor KL; Chen M
Oncotarget; 2016 Jun; 7(23):34630-42. PubMed ID: 27127879
[TBL] [Abstract][Full Text] [Related]
23. Promoter identification and transcriptional regulation of the metastasis gene MACC1 in colorectal cancer.
Juneja M; Ilm K; Schlag PM; Stein U
Mol Oncol; 2013 Oct; 7(5):929-43. PubMed ID: 23800415
[TBL] [Abstract][Full Text] [Related]
24. Statin and rottlerin small-molecule inhibitors restrict colon cancer progression and metastasis via MACC1.
Juneja M; Kobelt D; Walther W; Voss C; Smith J; Specker E; Neuenschwander M; Gohlke BO; Dahlmann M; Radetzki S; Preissner R; von Kries JP; Schlag PM; Stein U
PLoS Biol; 2017 Jun; 15(6):e2000784. PubMed ID: 28570591
[TBL] [Abstract][Full Text] [Related]
25. RAGE mediates S100A4-induced cell motility via MAPK/ERK and hypoxia signaling and is a prognostic biomarker for human colorectal cancer metastasis.
Dahlmann M; Okhrimenko A; Marcinkowski P; Osterland M; Herrmann P; Smith J; Heizmann CW; Schlag PM; Stein U
Oncotarget; 2014 May; 5(10):3220-33. PubMed ID: 24952599
[TBL] [Abstract][Full Text] [Related]
26. SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer.
Schmid F; Burock S; Klockmeier K; Schlag PM; Stein U
Mol Cancer; 2012 Jul; 11():49. PubMed ID: 22838389
[TBL] [Abstract][Full Text] [Related]
27. S100A4 promotes lung tumor development through β-catenin pathway-mediated autophagy inhibition.
Hou S; Tian T; Qi D; Sun K; Yuan Q; Wang Z; Qin Z; Wu Z; Chen Z; Zhang J
Cell Death Dis; 2018 Feb; 9(3):277. PubMed ID: 29449540
[TBL] [Abstract][Full Text] [Related]
28. Targeting S100A4 with niclosamide attenuates inflammatory and profibrotic pathways in models of amyotrophic lateral sclerosis.
Milani M; Mammarella E; Rossi S; Miele C; Lattante S; Sabatelli M; Cozzolino M; D'Ambrosi N; Apolloni S
J Neuroinflammation; 2021 Jun; 18(1):132. PubMed ID: 34118929
[TBL] [Abstract][Full Text] [Related]
29. DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer.
Kim HJ; Moon SJ; Kim SH; Heo K; Kim JH
Cell Death Dis; 2018 Aug; 9(8):831. PubMed ID: 30082743
[TBL] [Abstract][Full Text] [Related]
30. S100A4-induced cell motility and metastasis is restricted by the Wnt/β-catenin pathway inhibitor calcimycin in colon cancer cells.
Sack U; Walther W; Scudiero D; Selby M; Aumann J; Lemos C; Fichtner I; Schlag PM; Shoemaker RH; Stein U
Mol Biol Cell; 2011 Sep; 22(18):3344-54. PubMed ID: 21795396
[TBL] [Abstract][Full Text] [Related]
31. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
[TBL] [Abstract][Full Text] [Related]
32. Interplay between Trx-1 and S100P promotes colorectal cancer cell epithelial-mesenchymal transition by up-regulating S100A4 through AKT activation.
Zuo Z; Zhang P; Lin F; Shang W; Bi R; Lu F; Wu J; Jiang L
J Cell Mol Med; 2018 Apr; 22(4):2430-2441. PubMed ID: 29383839
[TBL] [Abstract][Full Text] [Related]
33. The anthelmintic niclosamide inhibits colorectal cancer cell lines via modulation of the canonical and noncanonical Wnt signaling pathway.
Monin MB; Krause P; Stelling R; Bocuk D; Niebert S; Klemm F; Pukrop T; Koenig S
J Surg Res; 2016 Jun; 203(1):193-205. PubMed ID: 27338550
[TBL] [Abstract][Full Text] [Related]
34. Extracellular ATP drives breast cancer cell migration and metastasis via S100A4 production by cancer cells and fibroblasts.
Liu Y; Geng YH; Yang H; Yang H; Zhou YT; Zhang HQ; Tian XX; Fang WG
Cancer Lett; 2018 Aug; 430():1-10. PubMed ID: 29733962
[TBL] [Abstract][Full Text] [Related]
35. MACC1 - more than metastasis? Facts and predictions about a novel gene.
Stein U; Dahlmann M; Walther W
J Mol Med (Berl); 2010 Jan; 88(1):11-8. PubMed ID: 19787327
[TBL] [Abstract][Full Text] [Related]
36. Repurposing of ingenol mebutate for treating human colorectal cancer by targeting S100 calcium-binding protein A4 (S100A4).
Hsieh YY; Cheng YW; Wei PL; Yang PM
Toxicol Appl Pharmacol; 2022 Aug; 449():116134. PubMed ID: 35724704
[TBL] [Abstract][Full Text] [Related]
37. MACC1 is post-transcriptionally regulated by miR-218 in colorectal cancer.
Ilm K; Fuchs S; Mudduluru G; Stein U
Oncotarget; 2016 Aug; 7(33):53443-53458. PubMed ID: 27462788
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
Wang G; Gu J; Gao Y
Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
[TBL] [Abstract][Full Text] [Related]
39. S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus.
Treese C; Hartl K; Pötzsch M; Dahlmann M; von Winterfeld M; Berg E; Hummel M; Timm L; Rau B; Walther W; Daum S; Kobelt D; Stein U
Cells; 2022 Mar; 11(6):. PubMed ID: 35326507
[TBL] [Abstract][Full Text] [Related]
40. Downregulation of S100A4 expression by RNA interference suppresses cell growth and invasion in human colorectal cancer cells.
Huang L; Xu Y; Cai G; Guan Z; Cai S
Oncol Rep; 2012 Apr; 27(4):917-22. PubMed ID: 22200787
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
